The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. NewAmsterdam Pharma Company NV shares valued at $11,600,000 were purchased by Douglas F Kling on Jan 27 ’25. At $23.20 per share, Douglas F Kling acquired 500,000 shares.
Also, Mayur Somalya purchased 200,000 shares, netting a total of over 4,640,000 in proceeds.
Before that, NAP PoolCo B.V. had added 1,396,241 shares to its account. In a trade valued at $35,338,860, the Affiliate bought NewAmsterdam Pharma Company NV shares for $25.31 each.
As published in their initiating research note from H.C. Wainwright on December 30, 2024, NewAmsterdam Pharma Company NV [NAMS] has been a Buy and the price target has been revised to $48. Analysts at TD Cowen started covering the stock with ‘”a Buy”‘ outlook in a report released in mid May. As of March 14, 2024, Scotiabank has initiated its “Sector outperform” rating for NAMS. Earlier on January 18, 2024, Guggenheim initiated its rating. Their recommendation was “a Buy” for NAMS stock.
Analyzing NAMS Stock Performance
During the last five days, there has been a surge of approximately 10.05%. Over the course of the year, NewAmsterdam Pharma Company NV shares have dropped approximately -18.64%. Shares of the company reached a 52-week high of $26.80 on 01/02/25 and a 52-week low of $17.18 on 02/25/25. A 50-day SMA is recorded $22.77, while a 200-day SMA reached $19.77. Nevertheless, trading volume fell to 1.13 million shares from 1.18 million shares the previous day.
Support And Resistance Levels for NewAmsterdam Pharma Company NV (NAMS)
According to the 24-hour chart, there is a support level at 20.05, which, if violated, would cause prices to drop to 19.18. In the upper region, resistance lies at 21.64. The next price resistance is at 22.36. RSI (Relative Strength Index) is 52.45 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.22, which suggests the price will decrease in the coming days. Percent R is at 13.66%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
